Inventor
HOFFMAN ROBERT LOUIS
US21 patents
⚠️ This page may combine multiple inventors who share the name “HOFFMAN ROBERT LOUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
18 patentsUS6992087B2Jan 31, 2006
Substituted aryl 1,4-pyrazine derivatives
PFIZER68 citations97
US8680111B2Mar 25, 2014
Macrocyclic derivatives for the treatment of diseases
PFIZER54 citations96
US7041672B2May 9, 2006
Substituted aryl 1, 4-pyrazine derivatives
PFIZER59 citations95
US10233188B2Mar 19, 2019
CDK2/4/6 inhibitors
PFIZER13 citations92
US11014911B2May 25, 2021
CDK2 inhibitors
PFIZER11 citations84
US9133215B2Sep 15, 2015
Macrocyclic derivatives for the treatment of diseases
PFIZER16 citations82
US11773082B2Oct 3, 2023
CDK2 inhibitors
PFIZER2 citations71
US11718603B2Aug 8, 2023
CDK2 inhibitors
PFIZER3 citations71
US10125130B2Nov 13, 2018
Cycloalkyl-linked diheterocycle derivatives
PFIZER2 citations71
US7087617B2Aug 8, 2006
Substituted pyrimidine derivatives
PFIZER6 citations62
US7015229B2Mar 21, 2006
Substituted pyrimidinones and pyrimidinthiones
PFIZER3 citations62
US11396512B2Jul 26, 2022
CDK2/4/6 inhibitors
PFIZER0 citations60
US12545669B2Feb 10, 2026
Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives
PFIZER0 citations59
US12485157B2Dec 2, 2025
Method of treating COVID-19
PFIZER0 citations50
US10676471B2Jun 9, 2020
Cycloalkyl-linked diheterocycle derivatives
PFIZER0 citations50
US10800783B2Oct 13, 2020
CDK2/4/6 inhibitors
PFIZER0 citations49
US11926642B2Mar 12, 2024
Compounds and methods for the treatment of COVID-19
PFIZER0 citations42
US7250418B2Jul 31, 2007
Compounds as CRF1 receptor antagonists
PFIZER0 citations41